9:00am - 5:00pm

Office Hours Mon. - Fri.


Call Us For Free Consultation



Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment

Estimated reading time: < 1 min


Malignant Pleural Mesothelioma

Estimated Enrollment: 78

Age Group: 18 Years to 85 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 86/12/02

Study First Received: November 10, 2010

Last Updated: November 17, 2010

Estimated Primary Completion Date: June 2010

Primary Outcome Measures:

Response rate|Safety and tolerability

Sponsors and Collaborators:

Institute of Oncology Ljubljana|Ministry of Higher Education, Science and Technology, Solvenia

Result Received: No Study Results Posted

Website Link: https://ClinicalTrials.gov/show/NCT01243632

Was this article helpful?
Views: 46